S-cubed Pharmaceutical Services ApS: Financial statements 2024
CVR: 39035448
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
S-cubed Pharmaceutical Services ApS (CVR 39035448) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -49,426 and a net result of DKK -51,181 compared with DKK 4,057 the year before. Equity in the 2024 report amounted to DKK 600,272. The solvency ratio was 98.1%.
- Gross Profit
- DKK -49,426
- Profit/Loss
- DKK -51,181
- Equity
- DKK 600,272
- Total Assets
- DKK 611,788
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -49K | -51K | 600K | - |
| 2023 | - | 4K | 4K | 651K | - |
| 2022 | - | 237K | 175K | 647K | - |
| 2021 | - | 397K | 323K | 473K | 1 |
| 2020 | - | 146K | 142K | 150K | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
S-cubed Pharmaceutical Services ApS has published its annual report for 2023. Gross profit came to DKK 4,245, and the net result was DKK 4,057.
About S-cubed Pharmaceutical Services ApS
S-cubed Pharmaceutical Services ApS is a Danish company of the type Anpartsselskab based in Frederikssund, founded in 2017. The company is registered under the industry Anden teknisk rådgivning. The management consists of Mark Dennis Lipscombe. The company is owned by S-Cubed Limited. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 1,235 and a net result of DKK -959 compared with DKK -51,181 the year before. Equity in the 2025 report amounted to DKK 599,313.